AQST is trading at $4.66, up 12.8% today after reporting a 66% year-over-year revenue increase and a significant surge in license and royalty income.
- Total revenue reached $14.4 million for the quarter, with license and royalty revenue jumping to $5.4 million from $0.8 million in the prior year.
- Management reaffirmed full-year 2026 guidance and confirmed the Anaphylm NDA resubmission is on track for the third quarter.
- Investor optimism is further supported by a strong cash position of $110.7 million to fund operational progress and key pipeline assets.